Fate Therapeutics, Inc.FATENASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR+18.5%
5Y CAGR+8.2%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+18.5%/yr
vs +24.9%/yr prior
5Y CAGR
+8.2%/yr
Recent acceleration
Acceleration
-6.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.38 | +40.5% |
| 2024 | 0.27 | -4.8% |
| 2023 | 0.28 | +24.4% |
| 2022 | 0.23 | +33.6% |
| 2021 | 0.17 | -33.2% |
| 2020 | 0.25 | +130.0% |
| 2019 | 0.11 | +18.6% |
| 2018 | 0.09 | -51.7% |
| 2017 | 0.19 | +31.3% |
| 2016 | 0.15 | - |